A novel ultrasensitive chemiluminescence enzyme immunoassay by employment of a signal enhancement of horseradish peroxidase-luminol-hydrogen peroxide reaction for the quantitation of atezolizumab, a monoclonal antibody used for cancer immunotherapy

This study describes, for the first time, the development and validation of a novel ultrasensitive chemiluminescence enzyme immunoassay (CLEIA) for the quantification of atezolizumab (ATZ), a monoclonal antibody approved by the FDA for treatment of different types of cancer. The assay involved the n...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	RSC advances 2024-03, Vol.14 (12), p.8167-8177
Hauptverfasser:	Darwish, Ibrahim A, Ali, Mohammad A. H, Alsalhi, Mohammed S, Zhang, Daohong
Format:	Artikel
Sprache:	eng
Schlagworte:	Blood plasma Cancer Chemiluminescence Chemistry Enzymes Hydrogen peroxide Immunoassay Monoclonal antibodies Peroxidase
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!